Categories
Connect with us on LinkedIn
Why a Life Sciences Museum Matters—And What It Can Teach Us About the Future of Medicine
What a Museum of Medicine can teach us about trials, trust, and how the public sees (or doesn’t...
Castor Steps Up to Preserve Critical Research Amid NIH Funding Cuts
Castor has announced free access to its clinical trial technology platform for U.S. researchers impacted by recent NIH...
How Advanced Neuromodulation Researchers Cut Study Build Time by 63% Using Integrated Trial Technology
This detailed case study reveals the practical strategies and technology solutions that enabled researchers to automate participant screening,...
Participant View eCOA | ePRO
What a participant sees on their own phone or a provisioned device, with invalid answers caught on their...
eCOA/ePRO factsheet
Download our ePRO/eCOA factsheet to view an overview of our services.
Strategies to Minimize Participant and Healthcare Provider Burden in Clinical Trials
This article examines strategies to reduce participant and provider burden in clinical trials while ensuring high-quality data collection....
What do we measure with PROs in head and neck cancer? Pain, QoL, adverse events and more
Patient-Reported Outcomes (PROs) are essential in head and neck cancer research, offering insights into symptoms, quality of life,...
2024: Castor Year in Review
As we close the year, the Castor team shares vital milestones the company has achieved to make patient-centric...
Unlocking FDA’s Vision for PRO Collection in RWE: Timing, Methods, and Insights
Discover FDA's guidance on collecting PROs for Real-World Evidence (RWE), focusing on timing, methods, and improving data quality.
FDA’s Vision on PRO/eCOA Collection for RWE: Timing and Methods Explained
Watch back as our panel of experts discuss how the FDA views the collection of patient-reported outcomes for...
Castor Launches “Castor for Impact Program” to Advance Health Equity in Clinical Research
Innovative Program Offers Discounted or Free Access to Clinical Trial Technology, Empowering Underserved Research Areas and Early-Stage Biotech...
DTx company leverages Castor’s Real-World Evidence platform in Registry study
How Castor’s eClinical system helped a DTx company to collect Real World Evidence for their behavioral disorder treatment
Castor Product Spotlight: What’s new in 2024?
In this on-demand webinar, we delve into the latest product updates on eCOA, data entry, reports, and dashboards....
eCOA: Afterthought or Essential Strategy? An Expert’s View on Choosing and Developing an eCOA Strategy
The Evolving Landscape of eCOA in Clinical Trials Clinical trials have long grappled with the complexities of data...
Evaluating “Bother” as a Component of Patient-Reported Outcomes in Clinical Studies
Patient-reported outcome (PRO) instruments refer to multiple scales and questionnaires designed to collect patients’ personal feedback on their...
New Industry Standard Research Report Sheds Light on eCOA/ePRO Market Dynamics
The latest report from Industry Standard Research (ISR) Sheds Light on eCOA/ePRO Market Dynamics. The Performance of Castor...
Under pressure: what it takes to validate a cuffless blood pressure device
When a company brings a cuffless, continuous blood pressure monitor to market, the wristband is the easy part....
Under Pressure: How Aktiia Brought Their Continuous BP Device to Global Markets with high quality data
Watch this on-demand LinkedIn Live webinar with Castor CEO & founder, Derk Arts, featuring fellow data-driven pioneer, Jay...
Connect with us on LinkedIn
